International Society of Nephrology Frontiers Meeting (ISN) 2022
Phase 3, Randomized, Multicenter Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Treatment of C3G or IC-MPGN
A Phase 2 Study to Evaluate the Efficacy and Safety of Pegcetacoplan in the Treatment of Patients With Post-transplant Recurrence of C3G or IC-MPGN